Synergistic Anti-Tumor Effects in RAS Mut Multiple Myeloma By Targeting MAP4K2 and RAS Pathways

Fu, J., Li, S., Liu, G., MA, H., Marcireau, C., Mapara, M., & Lentzsch, S. (2023). Synergistic Anti-Tumor Effects in RAS Mut Multiple Myeloma By Targeting MAP4K2 and RAS Pathways. Blood, 142(Supplement 1), 6618–6618. https://doi.org/10.1182/blood-2023-190740

Authors:

Jing Fu

Shirong Li

Guifen Liu

Huihui Ma

Christophe Marcireau

Markus Y. Mapara

Suzanne Lentzsch

Affiliated Authors:

Jing Fu

Shirong Li

Guifen Liu

Markus Y. Mapara

Suzanne Lentzsch

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Medicine
  Division of Hematology/Oncology

Subjects:

Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)

Mammalian MAP Kinase Signaling Pathways (OpenAlex Topic)

Role of Pim Oncogenes in Tumorigenesis (OpenAlex Topic)

elink

Publication Type:

Article

Unique ID:

10.1182/blood-2023-190740

DOI:

10.1182/blood-2023-190740

Journal:

Blood

Publication Date:

2023-11-02

Data Source:

OpenAlex

Source Link:

View OpenAlex Record

Record Created:

Wednesday, July 31, 2024 - 12:15